Published in Arch Ophthalmol on November 01, 2007
Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. Ophthalmology (2009) 2.99
Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS (2008) 2.15
Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. Arch Ophthalmol (2012) 1.43
Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges. Surv Ophthalmol (2009) 1.16
Plus disease in retinopathy of prematurity: qualitative analysis of diagnostic process by experts. JAMA Ophthalmol (2013) 1.09
Predictive value of pre-plus disease in retinopathy of prematurity. Arch Ophthalmol (2011) 1.05
Evolution of plus disease in retinopathy of prematurity: quantification by ROPtool. Trans Am Ophthalmol Soc (2009) 1.04
Computer-based image analysis for plus disease diagnosis in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus (2011) 1.03
Validating retinal fundus image analysis algorithms: issues and a proposal. Invest Ophthalmol Vis Sci (2013) 1.03
Plus disease diagnosis in retinopathy of prematurity: vascular tortuosity as a function of distance from optic disk. Retina (2013) 0.98
Plus disease in retinopathy of prematurity: diagnostic impact of field of view. Retina (2012) 0.98
OBSERVER AND FEATURE ANALYSIS ON DIAGNOSIS OF RETINOPATHY OF PREMATURITY. IEEE Int Workshop Mach Learn Signal Process (2012) 0.90
Evaluation of vascular disease progression in retinopathy of prematurity using static and dynamic retinal images. Am J Ophthalmol (2011) 0.87
Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. Ophthalmic Surg Lasers Imaging Retina (2014) 0.86
Macular findings obtained by spectral domain optical coherence tomography in retinopathy of prematurity. J Ophthalmol (2014) 0.86
Surgical management of retinopathy of prematurity. Curr Opin Ophthalmol (2008) 0.83
Telemedicine Applications in Pediatric Retinal Disease. J Clin Med (2017) 0.75
Technology and retinopathy of prematurity diagnosis: the new frontier. Arch Ophthalmol (2007) 0.75
Need for Refinement of International Retinopathy of Prematurity Guidelines and Classifications. J Ophthalmic Vis Res (2016) 0.75
ROPtool analysis of images acquired using a noncontact handheld fundus camera (Pictor)-a pilot study. J AAPOS (2015) 0.75
Using an Image Fusion Methodology to Improve Efficiency and Traceability of Posterior Pole Vessel Analysis by ROPtool. Open Ophthalmol J (2017) 0.75
Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years. JAMA Ophthalmol (2014) 3.88
Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol (2003) 3.58
Dynamics of human foveal development after premature birth. Ophthalmology (2011) 3.11
Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. Ophthalmology (2009) 2.99
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). J Clin Oncol (2013) 2.50
A pilot study using "ROPtool" to quantify plus disease in retinopathy of prematurity. J AAPOS (2007) 2.49
Retracted Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype. Am J Respir Crit Care Med (2012) 2.39
Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol (2015) 2.17
Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS (2008) 2.15
A distribution-free test of constant mean in linear mixed effects models. Stat Med (2008) 1.97
Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography. Arch Ophthalmol (2009) 1.93
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study. Leuk Lymphoma (2008) 1.91
Nonparametric inference on median residual life function. Biometrics (2007) 1.90
Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS (2007) 1.73
Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol (2003) 1.70
Optical coherence tomography in the eyes of normal children. Arch Ophthalmol (2009) 1.64
Choroid development and feasibility of choroidal imaging in the preterm and term infants utilizing SD-OCT. Invest Ophthalmol Vis Sci (2013) 1.64
Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Plast Reconstr Surg (2003) 1.58
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood (2011) 1.55
Mutational hotspots in the mitochondrial genome of lung cancer. Biochem Biophys Res Commun (2011) 1.54
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica (2011) 1.48
Retinopathy of prematurity care: patterns of care and workforce analysis. J AAPOS (2008) 1.48
A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254. Leuk Lymphoma (2011) 1.44
Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity. Arch Ophthalmol (2012) 1.43
A retrospective analysis of facial fracture etiologies. Ann Plast Surg (2008) 1.33
Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina (2011) 1.31
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg (2003) 1.28
Glaucoma-related adverse events in the Infant Aphakia Treatment Study: 1-year results. Arch Ophthalmol (2011) 1.25
Enhanced video indirect ophthalmoscopy (VIO) via robust mosaicing. Biomed Opt Express (2011) 1.24
Endoscopic laser cyclophotocoagulation in pediatric glaucoma with corneal opacities. J AAPOS (2007) 1.24
Gradient lasso for Cox proportional hazards model. Bioinformatics (2009) 1.21
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy. Lung Cancer (2012) 1.21
Statistical challenges in preprocessing in microarray experiments in cancer. Clin Cancer Res (2008) 1.19
Foveal hypoplasia in oculocutaneous albinism demonstrated by optical coherence tomography. Am J Ophthalmol (2002) 1.18
Subfoveal fluid in healthy full-term newborns observed by handheld spectral-domain optical coherence tomography. Am J Ophthalmol (2011) 1.18
Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity. J AAPOS (2005) 1.12
Central corneal thickness: congenital cataracts and aphakia. Am J Ophthalmol (2007) 1.11
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study. Cancer Invest (2004) 1.10
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Mol Cancer Ther (2010) 1.08
Combining ROPtool measurements of vascular tortuosity and width to quantify plus disease in retinopathy of prematurity. J AAPOS (2011) 1.07
Exploratory Dijkstra forest based automatic vessel segmentation: applications in video indirect ophthalmoscopy (VIO). Biomed Opt Express (2012) 1.07
Reversible retinal edema in an infant with neonatal hemochromatosis and liver failure. J AAPOS (2011) 1.05
Computer-assisted measurement of retinal vascular width and tortuosity in retinopathy of prematurity. Arch Ophthalmol (2010) 1.05
Appropriate design of prospective studies. J Clin Oncol (2012) 1.05
Macular and retinal nerve fiber layer analysis of normal and glaucomatous eyes in children using optical coherence tomography. Am J Ophthalmol (2005) 1.05
Predictive value of pre-plus disease in retinopathy of prematurity. Arch Ophthalmol (2011) 1.05
Aqueous drainage device surgery in refractory pediatric glaucomas: I. Long-term outcomes. J AAPOS (2007) 1.05
Evolution of plus disease in retinopathy of prematurity: quantification by ROPtool. Trans Am Ophthalmol Soc (2009) 1.04
Computer-assisted assessment of plus disease in retinopathy of prematurity using video indirect ophthalmoscopy images. Retina (2008) 1.04
Central corneal thickness and its relationship to intraocular pressure in children. Ophthalmology (2004) 1.03
Home assessment of diurnal intraocular pressure in healthy children using the Icare rebound tonometer. J AAPOS (2012) 1.02
Icare rebound tonometry in children with known and suspected glaucoma. J AAPOS (2011) 1.02
Statistical considerations for analysis of microarray experiments. Clin Transl Sci (2011) 1.00
A permutation-based multiple testing method for time-course microarray experiments. BMC Bioinformatics (2009) 1.00
Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes. Genet Epidemiol (2013) 1.00
A parametric model for long-term follow-up data from phase III breast cancer clinical trials. Stat Med (2003) 0.99
A pilot study using ROPtool to measure retinal vascular dilation. Retina (2009) 0.99
Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study. J Clin Oncol (2003) 0.98
Rank tests for clustered survival data when dependent subunits are randomized. Stat Med (2006) 0.98
Acquired central corneal thickness increase following removal of childhood cataracts. Am J Ophthalmol (2011) 0.98
Reproducibility of spectral-domain optical coherence tomography measurements in adult and pediatric glaucoma. J Glaucoma (2015) 0.98
Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology (2005) 0.97
permGPU: Using graphics processing units in RNA microarray association studies. BMC Bioinformatics (2010) 0.96
APOE related hippocampal shape alteration in geriatric depression. Neuroimage (2008) 0.96
CYP1B1, MYOC, and LTBP2 mutations in primary congenital glaucoma patients in the United States. Am J Ophthalmol (2012) 0.95
Designing phase II studies in cancer with time-to-event endpoints. Clin Trials (2008) 0.95
Fiber tract-specific white matter lesion severity Findings in late-life depression and by AGTR1 A1166C genotype. Hum Brain Mapp (2011) 0.94
Tortuosity of arterioles and venules in quantifying plus disease. J AAPOS (2009) 0.93
Differentiating glaucomatous from non-glaucomatous optic nerve cupping by optical coherence tomography. Open Neurol J (2011) 0.93
A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer. Ann Surg (2016) 0.92
Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents. Medicine (Baltimore) (2016) 0.92
Central corneal thickness in children and adolescents with pediatric glaucoma and eye disorders at risk of developing glaucoma. J Pediatr Ophthalmol Strabismus (2010) 0.90
Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study. Ophthalmology (2011) 0.90
Central corneal thickness in children: Racial differences (black vs. white) and correlation with measured intraocular pressure. J Glaucoma (2006) 0.89
Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma. Mol Cancer Ther (2010) 0.89
Postoperative prognosis prediction of pancreatic cancer with seven microRNAs. Pancreas (2015) 0.88
Icare ONE rebound versus Goldmann applanation tonometry in children with known or suspected glaucoma. Am J Ophthalmol (2012) 0.88
Effect of dropouts on sample size estimates for test on trends across repeated measurements. J Biopharm Stat (2005) 0.87
The accuracy of photoscreening at detecting treatable ocular conditions in children with Down syndrome. J AAPOS (2010) 0.87
Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test. Stat Med (2013) 0.87
Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. Ophthalmic Surg Lasers Imaging Retina (2014) 0.86
Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study. Ophthalmology (2011) 0.86
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients. Invest New Drugs (2013) 0.86
Power and sample size calculations for SNP association studies with censored time-to-event outcomes. Genet Epidemiol (2012) 0.86
Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline. Reprod Sci (2007) 0.85
Latanoprost for the treatment of pediatric glaucoma. Surv Ophthalmol (2002) 0.84
Physician self-referral of lumbar spine MRI with comparative analysis of negative study rates as a marker of utilization appropriateness. AJR Am J Roentgenol (2012) 0.84
Postoperative cilioretinal artery occlusion in Sturge Weber-associated glaucoma. J AAPOS (2010) 0.84
Latanoprost in pediatric glaucoma--pediatric exposure over a decade. J AAPOS (2009) 0.84
Surgical outcomes in childhood uveitic glaucoma. Am J Ophthalmol (2012) 0.83
A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701. Cancer (2013) 0.83
Fibrovascular ingrowth as a cause of Ahmed glaucoma valve failure in children. Am J Ophthalmol (2006) 0.83